Characteristics of the patients treated with intra-articular corticosteroids (IAC) or infliximab
| Treatment groups | ||
|---|---|---|
| IAC | Infliximab | |
| –, value not determined. | ||
| Age, median (range), years | 51.2 (21–83) | 50.5 (25.0–74.0) |
| Female/male | 15/4 | 25/9 |
| Disease duration, median (range), years | 7.5 (0.3–23) | 10.8 (0.6–30.0) |
| S100A12 serum levels before therapy, ng/ml (±SEM) | 585 (±170) | 430 (±65) |
| S100A12 serum levels after therapy, ng/ml (±SEM) | 490 (±160) | 290 (±55) |
| CRP before therapy, mg/dl (±SEM) | – | 3.2 (±0.9) |
| CRP after therapy, mg/dl (±SEM) | – | 1.0 (±0.3) |
| ESR before therapy, mm/h (±SEM) | – | 23 (±4) |
| ESR after therapy, mm/h (±SEM) | – | 11 (±2) |
| Number of patients with concomitant therapy: | ||
| MTX (>7.5 mg/week) | 7/19 | 26/34 |
| Systemic corticosteroids | 4/19 | 14/34 |